AstraZeneca-Oxford - Latest News Update, Information, Photos & Videos on AstraZeneca-Oxford at Lokmat Times

New Delhi, Sep 10 Pharma major AstraZeneca has said it is working to expedite the review of the single event to minimise any potential impact on the trial timeline of its Covid-19 vaccine candidate.AstraZeneca said in a statement that as part of the ongoing randomised, controlled clinical trials of the AstraZeneca Oxford coronavirus vaccine, AZD1222, a standard review process has been triggered.The review process has led to the voluntary pause of vaccination across all trials to allow an independent committee to review the safety data of a single event of an unexplained illness that occurred in the UK Phase III trial, the company said."This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials", it said."In large clinical trials, illnesses will happen by chance and must be independently reviewed. AstraZeneca is working to expedite the review of the single event to minimise any potential impact on the trial timeline. We are committed to the safety of our participants and the highest standards of conduct in our trials", the company said.Pascal Soriot, Chief Executive Officer, said: "At AstraZeneca we put science, safety and the interests of society at the heart of our work. This temporary pause is living proof that we follow those principles while a single event at one of our trial sites is assessed by a committee of independent experts. We will be guided by this committee as to when the trials could restart, so that we can continue our work at the earliest opportunity to provide this vaccine broadly, equitably and at no profit during this pandemic."( With inputs from IANS )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Lok Sabha Election 2024

Heatwave In India

Mumbai Water Cut

Maharashtra Lok Sabha Election

IPL 2024

Salman Khan

Astrazeneca-OxfordFOLLOW

Astrazeneca-oxford, Latest News

International :AstraZeneca resumes US COVID-19 vaccine trial

The clinical trials for the AstraZeneca Oxford coronavirus vaccine -- AZD1222 -- have resumed in the United States after approval by the Food and Drug Administration (FDA), the company said on Friday (local time). ...

International :COVID-19 Vaccine: AstraZeneca COVID-19 vaccine trial Brazil volunteer dies

A volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca AZN.L and Oxford University died on ... ...

Health :Panel to decide on AstraZeneca Covid vax trials after unexplained illness in UK

New Delhi, Sep 10 Pharma major AstraZeneca has said it is working to expedite the review of the ... ...